Corporate ActionJul 10, 2026, 04:08 PM
Traws Pharma to sell up to $5.58M in common stock via ATM offering
AI Summary
Traws Pharma, Inc. has updated its At The Market (ATM) Offering Agreement with Citizens JMP Securities, LLC, allowing the company to offer and sell shares of its common stock. Initially, the agreement permitted sales up to $50,000,000. Under a new prospectus supplement dated July 10, 2026, the company may now sell shares with an aggregate offering price of up to $5,575,709, utilizing its effective shelf registration statement on Form S-3.
Key Highlights
- Entered At The Market (ATM) Offering Agreement with Citizens JMP Securities, LLC.
- May offer and sell shares of common stock under the ATM Agreement.
- Initial aggregate sales price up to $50,000,000.
- Current aggregate offering price up to $5,575,709 under new prospectus.
- Sales conducted pursuant to effective shelf registration statement on Form S-3.
- Prospectus Supplement dated July 10, 2026, filed with the Commission.
- Legal opinion from Snell & Wilmer L.L.P. filed as Exhibit 5.1.
Price Impact
More from TRAW